Evidence map›Paper›PMID 14970390›Full record

ArticleRNA (New York, N.Y.)2004

Characterization of deadenylation in trypanosome extracts and its inhibition by poly(A)-binding protein Pab1p.

Joseph Milone, Jeffrey Wilusz, Vivian Bellofatto

Open access · bronzeAbstract read
In one paragraph

Article in RNA (New York, N.Y.), 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 30 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Inhibition of tristetraprolin deadenylation by poly(A) binding protein.American journal of physiology. Gastrointestinal and liver physiology · 2008
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Joseph MiloneDepartment of Microbiology and Molecular Genetics, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, International Center for Public Health, Newark, New Jersey 07103, USA.
Jeffrey Wilusz
Vivian Bellofatto
Rutgers, The State University of New Jersey · USColorado State University · US

Funding

TRYPANOSOME MRNA SYNTHESIS BY GENE TRANSFERR01AI029478 · NIAID · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI BELLOFATTO, VIVIAN · 1991 to 2010
$4.6M
Regulation of mRNA Decapping in Human CellsR01GM063832 · NIGMS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI WILUSZ, JEFFREY · 2001 to 2004
$1.0M
NCI NIH HHS CA80062NIAID NIH HHS AI29478NIAID NIH HHS R01 AI029478NIGMS NIH HHS GM63832NIGMS NIH HHS R01 GM063832
6 · The paper itself

Abstract

The stability of mRNAs is an important point in the regulation of gene expression in eukaryotes. The mRNA turnover pathways have been identified in yeast and mammals. However, mRNA turnover pathways in trypanosomes have not been widely studied. Deadenylation is the first step in the major mRNA turnover pathways of yeast and mammals. To better understand mRNA degradation processes in these organisms, we have developed an in vitro mRNA turnover system that is functional for deadenylation. In this system, addition of poly(A) homopolymer activates the deadenylation of poly(A) tails. The trypanosomal deadenylase activity is a 3'-->5' exonuclease specific for adenylate residues, generates 5'-AMP as a product, is magnesium dependent, and is inhibited by neomycin B sulfate. These characteristics suggest similarity with other eukaryotic deadenylases. Furthermore, this activity is cap independent, indicating a potential difference between the trypanosomal activity and PARN, but suggesting similarity to Ccr4p/Pop2p activities. Extracts immunodepleted of Pab1p required the addition of poly(A) competition to activate deadenylation. Trypanosomal Pab1p functions as an inhibitor of the activity under in vitro conditions. Pab1p appears to be one of several mRNA stability proteins in trypanosomal extracts.

Indexed as

AdenosineAnimalsPoly(A)-Binding Protein IPolymersRNA, MessengerTrypanosomatinaAdenosinePoly(A)-Binding Protein IpolyadenosinePolymersRNA, Messenger

Identifiers

PMID14970390
PMCPMC1370940
OpenAlexW2168806010

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.